Editas Medicine Inc buy Slaandjivaa
Start price
22.01.18
/
50%
€30.80
Target price
23.07.18
€34.28
Performance (%)
6.15%
End price
23.07.18
€32.70
Summary
This prediction ended on 23.07.18 with a price of €32.70. The BUY prediction by Slaandjivaa finished with a performance of 6.15%. Slaandjivaa has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Editas Medicine Inc | -4.426% | -4.426% | 46.667% | -75.766% |
| iShares Core DAX® | -1.875% | 2.861% | 18.863% | 63.672% |
| iShares Nasdaq 100 | -2.177% | 0.048% | 3.956% | 109.562% |
| iShares Nikkei 225® | -0.867% | 6.987% | 21.062% | 54.912% |
| iShares S&P 500 | -1.253% | 1.248% | 2.246% | 69.801% |
Comments by Slaandjivaa for this prediction
In the thread Editas Medicine Inc diskutieren
Edit besser als Crispr?
(Laufzeit überschritten)